home > newsroom
 
 
Dated: February 10,2014
Headline: Biological E awarded ISO 14001:2004 and OHSAS 18001:2007
  Hyderabad based Biological E Limited has been awarded ISO 14001:2004 and OHSAS 18001:2007 for Development, Manufacture and Supply of Bulk Antigens and Vaccines by SGS Societe Generale de Surveillance SA, Switzerland.
Dated: July 22, 2013
Headline: Biological E, JEEV Vaccine Prequalified by WHO – Hyderabad
  Hyderabad-based biopharmaceutical company Biological E (BioE) on Monday said, the WHO has prequalified its Japanese Encephalitis vaccine for global use in adults. The company expects that paediatric indication will also be prequalified by the end of the year……
Dated: July 08th, 2013
Headline: Biological E has entered into an agreement with Novartis
  Biological E has entered into an agreement with Novartis to license two vaccines to protect against typhoid and paratyphoid fevers. The vaccines are currently under development. BioE is committed to achieving World Health Organization (WHO) pre-qualification for the vaccines. The agreement is worldwide except for developed countries ........
Dated: June 28th, 2013
Headline: Biological E to supply vaccines to Egypt – Hyderabad
  Leading Indian biopharmaceutical firm Biological E Ltd. will supply pentavalent vaccines to Egypt - a combination of five vaccines-in-one (against diphtheria, tetanus, whooping cough, hepatitis B and haemophilus influenza type B) in a single dose. "We have entered into $200-million……
Dated: June 01st, 2013
Headline: Bill Gates visits Biological E
  Bill Gates, co-chairman of Bill & Melinda Gates Foundation, visited Biological E Ltd here on Friday and held discussion with the functionaries of the company on the supply of vaccines to the foundation……
Dated: April 18th, 2013
Headline: Biological E cuts price of PENTAVALENT
  GENEVA, 18th April 2013 – The cost of immunising millions of the world’s most vulnerable children against Five deadly and debilitating diseases is set to fall, thanks to a major price reduction of one third for pentavalent vaccine. This new, more cost-effective price provides the opportunity …….
Dated: April 15th, 2013
Headline: Biological E Appoints Mahima Datla as Managing Director
  The board of directors of Biological E Ltd has appointed Mahima Datla as Managing Director and inducted three new directors on the board.....
Dated: January 30th, 2013
Headline: FABA AWARD for Dr. Vijaya Kumar Datla
  Dr Vijay Kumar Datla, chairman and managing director of Biological E, will be given FABA Special Award 2013 at BioAsia 2013 today. Biological E is one of the leading vaccine manufacturers in India.....
Dated: January 28th, 2013
Headline: GSK and BIOLOGICAL E JOINT VENTURE TO DEVELOP COMBINATION VACCINE
  GlaxoSmithKline (GSK) and Biological E Limited (Biological E.), a leading Indian vaccines company, today announced an agreement to form a 50/50 joint venture.....
Dated: September 13th, 2012
Headline: Biological E ltd, Hyderabad launches JEEV - Inactivated Japanese Encephalitis Vaccine
  Biological E Ltd, one of the leading Indian Vaccine manufacturers based at Hyderabad announced the launch of its latest vaccine – Inactivated Japanese Encephalitis Vaccine which is to be marketed under the brand name “JEEV”.....
Dated: December 9
Headline: Biological E to launch new vaccines
  Biological Evans Ltd, at Hyderabad based biological Product manufacturer, plans to roll out its products from its upcoming biotech facility, with an ........
 
Dated: December 9
Headline: Biological Evans to make combination vaccine
  To consolidate its business in the human vaccine business, Biological Evans Ltd (BE) has proposed to diversify into 'combination vaccines'..........
 
Dated: December 9
Headline: Biological E bets future on combination vaccines
  In bid to put the company on growth path and meet the post-2005 challenges.Biological E (BE), which celebrates its 50th anniversary this week............
 
Dated: March 19
Headline: Biological E, Intercell tie-up to manufacture vaccine
  Biological E, a Hyderabad-based vaccine and pharmaceutical company, has tied up with Intercell AG, a Vienna-based biotech firm, to develop......
 
Dated: August 7
Headline: Vaccine diplomacy blurs K-hostility
  As India and Pakistan plough on the frigid heights of Saichen for a thaw in ties, there is a new born homie quietly sweeping the two countries...........